SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-024222
Filing Date
2023-08-21
Accepted
2023-08-21 08:12:44
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A tmbr20230821_defa14a.htm DEFA14A 68601
2 EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER, DATED AUGUST 20,2023 BY AND AMONG TIMB ex_562857.htm EX-2.1 768465
3 EXHIBIT 10.1 AMENDMENT NO.2 TO ASSET ACQUISITION AGREEMENT DATED AUGUST 20, 2023 ex_562858.htm EX-10.1 33649
4 PRESS RELEASE, DATE AUGUST 21, 2023 ex_562859.htm EX-99.1 22374
  Complete submission text file 0001437749-23-024222.txt   894244
Mailing Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059
Business Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059 (917) 697-3130
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37411 | Film No.: 231187383
SIC: 2834 Pharmaceutical Preparations